TABLE 3.

Determinants of MRA in patients with kidney failure treated with PD.

	Univariate analysis			Multivariate analysis
	Coeff.	95% CI	P-value	Coeff.	95% CI	P-value
Age—years	–0.36	−0.46, −0.26	<0.001	–0.20	−0.34, −0.06	0.004
Female gender	–4.86	−9.63, −0.08	0.05	–6.60	−10.20, −3.00	<0.001
Diabetes	–6.68	−11.66, −1.70	0.009	3.14	−1.26,7.54	0.2
Charlson comorbidity index	–2.09	−2.81, −1.36	<0.001	–0.69	−1.56,0.19	0.1
Visceral fat area—cm2	–0.05	−0.07, −0.03	<0.001	–0.05	−0.07, −0.02	<0.001
Serum albumin g/L	0.31	0.03,0.59	0.03	0.24	−0.02,0.50	0.07
Urine volume—mL	2.66×10−3	$0.91\times 10{}^{-3},4.42\times 10{}^{-3}$	0.003	2.23×10−3	$0.33\times 10{}^{-3},4.13\times 10{}^{-3}$	0.02
Time on dialysis
Year 1	1.00(ref.)	−	−	1.00(ref.)	−	−
Year 2	–1.84	−4.29,0.61	0.1	0.81	−1.24,2.85	0.4
Year 3	–4.32	−7.13, −1.51	0.003	0.22	−2.82,3.26	0.9
Year 4	–3.05	−6.08, −0.02	0.05	–0.27	−3.43,2.88	0.9
Constant				45.39	33.24,57.24	<0.001

Coeff., coefficient; CI, confidence interval.